Visualization and Sequencing of Accessible Chromatin Reveals Cell Cycle and Post-HDAC inhibitor Treatment Dynamics.


Journal

Journal of molecular biology
ISSN: 1089-8638
Titre abrégé: J Mol Biol
Pays: Netherlands
ID NLM: 2985088R

Informations de publication

Date de publication:
04 09 2020
Historique:
received: 23 04 2020
revised: 29 06 2020
accepted: 28 07 2020
pubmed: 9 8 2020
medline: 10 3 2021
entrez: 9 8 2020
Statut: ppublish

Résumé

Chromatin accessibility is a predictor of gene expression, cell division, and cell type specificity. NicE-viewSeq (Nicking Enzyme-assisted viewing and Sequencing) allows accessible chromatin visualization and sequencing with overall lower mitochondrial DNA and duplicated sequences interference relative to ATAC-see. Using NicE-viewSeq, we interrogated the accessibility of chromatin in a cell cycle (G1, S, and G2/M)-specific manner using mammalian cells. Despite DNA replication and subsequent condensation of chromatin to chromosomes, chromatin accessibility remained generally preserved with minimal subtle alterations. Genome-wide alteration of chromatin accessibility within TSS and enhancer elements gradually decreased as cells progressed from G1 to G2M, with distinct differential accessibility near consensus transcription factors sites. Inhibition of histone deacetylases promoted accessible chromatin within gene bodies, correlating with apoptotic gene expression. In addition, reduced chromatin accessibility for the MYC oncogene pathway correlated with downregulation of pertinent genes. Surprisingly, repetitive RNA loci expression remained unaltered following histone acetylation-mediated increased accessibility. Therefore, we suggest that subtle changes in chromatin accessibility are a prerequisite during the cell cycle and histone deacetylase inhibitor-mediated therapeutics.

Identifiants

pubmed: 32763232
pii: S0022-2836(20)30480-0
doi: 10.1016/j.jmb.2020.07.023
pii:
doi:

Substances chimiques

Chromatin 0
Depsipeptides 0
Histone Deacetylase Inhibitors 0
romidepsin CX3T89XQBK

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

5304-5321

Informations de copyright

Copyright © 2020 Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Conflict of Interest The authors declare no potential conflicts of interest

Auteurs

Pierre-Olivier Estève (PO)

Genome Biology Division, New England Biolabs, Inc., Ipswich, MA 01938, USA.

Udayakumar S Vishnu (US)

Genome Biology Division, New England Biolabs, Inc., Ipswich, MA 01938, USA.

Hang Gyeong Chin (HG)

Genome Biology Division, New England Biolabs, Inc., Ipswich, MA 01938, USA.

Sriharsa Pradhan (S)

Genome Biology Division, New England Biolabs, Inc., Ipswich, MA 01938, USA. Electronic address: pradhan@neb.com.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH